Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Delsing

Showing results (191-200 of 198) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 198 results.
International Journal of Behavioral Medicine|January 23, 2026
Fatigue in COPD: a Longitudinal, Multidimensional PerspectiveZjala Ebadi, Yvonne M J Goërtz, Maarten Van Herck, et al.
Leukemia|November 27, 2019
MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cellsEdith Schneider, Nicole Pochert, Christoph Ruess, et al.
Clinical and Vaccine Immunology : CVI|March 24, 2012
Microbiological challenges in the diagnosis of chronic Q feverLinda M Kampschreur, Jan Jelrik Oosterheert, Annemarie M C Koop, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 30, 2017
Declining Hepatitis C Virus (HCV) Incidence in Dutch Human Immunodeficiency Virus-Positive Men Who Have Sex With Men After Unrestricted Access to HCV TherapyAnne Boerekamps, Guido E van den Berk, Fanny N Lauw, et al.
Open Forum Infectious Diseases|April 3, 2024
Dolutegravir/Lamivudine Is Noninferior to Continuing Dolutegravir- and Non-Dolutegravir-Based Triple-Drug Antiretroviral Therapy in Virologically Suppressed People With Human Immunodeficiency Virus: DUALING Prospective Nationwide Matched Cohort StudyMarta Vasylyev, Ferdinand W N M Wit, Carlijn C E Jordans, et al.
The Journal of Infectious Diseases|November 19, 2022
Immunogenicity of an Additional mRNA-1273 SARS-CoV-2 Vaccination in People With HIV With Hyporesponse After Primary VaccinationMarlou J Jongkees, Daryl Geers, Kathryn S Hensley, et al.
Plos Medicine|January 7, 2023
Correction: Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort studyKathryn S Hensley, Marlou J Jongkees, Daryl Geers, et al.
Plos Medicine|October 27, 2022
Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort studyKathryn S Hensley, Marlou J Jongkees, Daryl Geers, et al.
Pageof 20

Showing results (191-200 of 198) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 198 results.
International Journal of Behavioral Medicine|January 23, 2026
Fatigue in COPD: a Longitudinal, Multidimensional PerspectiveZjala Ebadi, Yvonne M J Goërtz, Maarten Van Herck, et al.
Leukemia|November 27, 2019
MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cellsEdith Schneider, Nicole Pochert, Christoph Ruess, et al.
Clinical and Vaccine Immunology : CVI|March 24, 2012
Microbiological challenges in the diagnosis of chronic Q feverLinda M Kampschreur, Jan Jelrik Oosterheert, Annemarie M C Koop, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 30, 2017
Declining Hepatitis C Virus (HCV) Incidence in Dutch Human Immunodeficiency Virus-Positive Men Who Have Sex With Men After Unrestricted Access to HCV TherapyAnne Boerekamps, Guido E van den Berk, Fanny N Lauw, et al.
Open Forum Infectious Diseases|April 3, 2024
Dolutegravir/Lamivudine Is Noninferior to Continuing Dolutegravir- and Non-Dolutegravir-Based Triple-Drug Antiretroviral Therapy in Virologically Suppressed People With Human Immunodeficiency Virus: DUALING Prospective Nationwide Matched Cohort StudyMarta Vasylyev, Ferdinand W N M Wit, Carlijn C E Jordans, et al.
The Journal of Infectious Diseases|November 19, 2022
Immunogenicity of an Additional mRNA-1273 SARS-CoV-2 Vaccination in People With HIV With Hyporesponse After Primary VaccinationMarlou J Jongkees, Daryl Geers, Kathryn S Hensley, et al.
Plos Medicine|January 7, 2023
Correction: Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort studyKathryn S Hensley, Marlou J Jongkees, Daryl Geers, et al.
Plos Medicine|October 27, 2022
Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort studyKathryn S Hensley, Marlou J Jongkees, Daryl Geers, et al.
Pageof 20